Literature DB >> 15135709

Coronary artery disease and opioid use.

Michael Marmor1, Arthur Penn, Kyle Widmer, Richard I Levin, Robert Maslansky.   

Abstract

Over the past 20 years, we have observed a paucity of morbidity and mortality due to cardiovascular disease among drug users in a methadone maintenance clinic. The present study investigated whether long-term exposure to opiates or opioids is associated with decreased severity of coronary artery disease (CAD) by comparing 98 decedents with methadone or opiates (M/O) in their blood at autopsy with 97 frequency-matched decedents without M/O. Severe CAD was found significantly less often in M/O-positive decedents (5 of 98) than in M/O-negative decedents (16 of 97). Multiple logistic regression analysis contrasting those with moderate or severe CAD to those with no or mild CAD yielded an odds ratio of 0.43 (95% confidence interval 0.20 to 0.94) for M/O positivity after adjustment for potential confounding. Long-term opiate exposure thus may mitigate CAD severity and its often fatal consequences.

Entities:  

Mesh:

Year:  2004        PMID: 15135709     DOI: 10.1016/j.amjcard.2004.01.072

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

Review 1.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

Review 2.  Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Angela Mailis-Gagnon; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

Review 3.  Opioid-induced cardioprotection.

Authors:  Katsuya Tanaka; Judy R Kersten; Matthias L Riess
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Opium Addiction and Correlation with Early and Six-month Outcomes of Presenting with ST Elevation Myocardial Infarction Treated Initially with Thrombolytic Therapy.

Authors:  Mehdi Mousavi; Solmaz Kalhor; Mahlaa Alizadeh; Mohamad Reza Movahed
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

5.  Sustained ligand-activated preconditioning via δ-opioid receptors.

Authors:  Jason N Peart; Louise E See Hoe; Garrett J Gross; John P Headrick
Journal:  J Pharmacol Exp Ther       Date:  2010-10-14       Impact factor: 4.030

6.  Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study.

Authors:  Zahra Jamali; Mojgan Noroozi Karimabad; Parvin Khalili; Tabandeh Sadeghi; Ahmadreza Sayadi; Faegheh Mohammadakbari Rostamabadi; Carlo La Vecchia; Ali Esmaeili-Nadimi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

7.  Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.

Authors:  Eric R Gross; Anna K Hsu; Garrett J Gross
Journal:  Anesth Analg       Date:  2009-11       Impact factor: 5.108

8.  Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study.

Authors:  Mahdi Nalini; Ramin Shakeri; Hossein Poustchi; Akram Pourshams; Arash Etemadi; Farhad Islami; Masoud Khoshnia; Abdolsamad Gharavi; Gholamreza Roshandel; Hooman Khademi; Mahdi Zahedi; Behnoush Abedi-Ardekani; Rajesh Vedanthan; Paolo Boffetta; Sanford M Dawsey; Paul D Pharaoh; Masoud Sotoudeh; Christian C Abnet; Nicholas E Day; Paul Brennan; Farin Kamangar; Reza Malekzadeh
Journal:  Eur J Prev Cardiol       Date:  2021-03-23       Impact factor: 7.804

9.  Opium addiction and severity of coronary artery disease: a case-control study.

Authors:  Mohammad Masoumi; Armita Shahesmaeili; Ali Mirzazadeh; Marjan Tavakoli; Arghavan Zia Ali
Journal:  J Res Med Sci       Date:  2010-01       Impact factor: 1.852

10.  The relationship of opium addiction with coronary artery disease.

Authors:  Mohammad Masoomi; Mohammad Arash Ramezani; Hadi Karimzadeh
Journal:  Int J Prev Med       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.